Photo of Janice D. Schakowsky
D United States House · District 9 · Illinois

Rep. Janice D. Schakowsky

Compare
Total votes
2,837
all sessions
Attendance
97%
99 missed
Lower than 88% of chamber peers
With party
97%
of cast votes
Higher than 80% of chamber peers
Bipartisan score
1%
crosses aisle rarely
Lower than 80% of chamber peers
Sponsored
2,557
bills & resolutions
Higher than 92% of chamber peers
Committees
3
assignments
2,557 bills and resolutions

Sponsored bills

Total
2,557
Primary
150
Co-sponsor
2,407
This page
2,557
matching current filters
Co-sponsor HJRES 4
In committee · United States House · Co-sponsor
Proposing an amendment to the Constitution of the United States limiting the pardon power of the President.

This joint resolution proposes a constitutional amendment limiting the pardon power of the President. The amendment prohibits the President from granting a pardon or reprieve to himself or herself, to family members or members of the administration, to paid campaign employees, to a person or entity for an offense motivated by an interest of any of those people, or to a person or entity for an offense directed by or coordinated with the President. The amendment also invalidates pardons issued for a corrupt purpose.

In committee Mar 4, 2021 1 co-sponsor
Co-sponsor HRES 25
In committee · United States House · Co-sponsor
Directing the Committee on Ethics to investigate, and issue a report on, whether any and all actions taken by Members of the 117th Congress who sought to overturn the 2020 Presidential election violated their oath of office to uphold the Constitution or the Rules of the House of Representatives, and should face sanction, including removal from the House of Representatives.

This resolution requires the House Committee on Ethics to investigate and report on whether (1) actions taken by Members of the 117th Congress seeking to overturn the 2020 Presidential election violated their oath of office; and (2) these Members should face sanction, including removal from the House of Representatives. It also condemns all targeted and malicious efforts to disenfranchise Black, Brown, and Indigenous voters.

In committee Mar 4, 2021 1 co-sponsor
Co-sponsor HRES 32
In committee · United States House · Co-sponsor
Impeaching Donald John Trump, President of the United States, for high crimes and misdemeanors.

This resolution impeaches President Donald John Trump for high crimes and misdemeanors. Specifically, the resolution sets forth two articles of impeachment. The first article states that President Trump abused the powers of the presidency by attempting to unlawfully overturn the results of Georgia's presidential election. The article specifies that President Trump, on a recorded call, repeatedly asked the Secretary of State of Georgia to overturn the verified results of the election and threatened consequences for a failure to do so. The second article states that President Trump abused the powers of the presidency by inciting violence and orchestrating an attempted coup. The article specifies that, on January 6, 2021, President Trump incited a crowd of supporters to attack the Capitol while Congress was in session to certify the results of the election. The article further specifies that, after those supporters had violently breached the Capitol, President Trump made a statement repeating his false claims of election fraud and expressing affection for the supporters. Both articles state that, by such conduct, President Trump warrants impeachment and trial, removal from office, and disqualification from holding U.S. office.

In committee Mar 4, 2021 1 co-sponsor
Co-sponsor HRES 14
In committee · United States House · Co-sponsor
Censuring and condemning President Donald J. Trump for attempting to overturn the results of the November 2020 presidential election in the State of Georgia.

This resolution censures and condemns President Donald J. Trump for asking the Georgia Secretary of State on January 2, 2021, to overturn the Georgia results of the November 2020 presidential election. It further calls on President Trump to (1) retract and disavow this behavior, and (2) acknowledge President-elect Joseph R. Biden as the victor of the November 2020 presidential election.

In committee Mar 4, 2021 1 co-sponsor
Co-sponsor HR 1587
In committee · United States House · Co-sponsor
Medicare Audiologist Access and Services Act of 2021

Medicare Audiologist Access and Services Act of 2021 This bill provides for Medicare coverage of certain audiologist services. Specifically, the bill expands coverage to include diagnostic and treatment services that are furnished by audiologists and that would otherwise be covered if provided by a physician, including incidental services, regardless of whether such services are provided pursuant to a referral from, or under the supervision of, a physician or other health care practitioner.

In committee Mar 4, 2021 1 co-sponsor
Co-sponsor HR 1551
In committee · United States House · Co-sponsor
Nutrition CARE Act of 2021

Nutrition Counseling Aiding Recovery for Eating Disorders Act of 2021 or the Nutrition CARE Act of 2021 This bill provides for Medicare coverage of medical nutrition therapy services for individuals with eating disorders. Such services must be furnished by a registered dietitian or nutrition professional pursuant to a referral from a physician, psychologist, or other authorized mental health professional.

In committee Mar 4, 2021 1 co-sponsor
Co-sponsor HR 276
In committee · United States House · Co-sponsor
Congressional Oversight of Unjust Policing Act

Congressional Oversight of Unjust Policing Act This bill establishes the U.S. Commission on Unjust Policing to investigate law enforcement activities and decisions related to the security breach at the U.S. Capitol on January 6, 2021. Specifically, the commission must investigate decisions made by leadership of the U.S. Capitol Police (USCP), the Federal Bureau of Investigation, the U.S. Secret Service, and the Department of Homeland Security leading up to and during the siege at the Capitol, including an assessment of whether conscious and unconscious bias was a factor in the miscalculation of the risk posed by protesters to Members of Congress and their staff. The commission must also investigate whether current USCP officers have ties to white supremacist and other extremist groups, movements, and organizing efforts, and whether any USCP officers neglected their duty and colluded with protestors or other law enforcement entities. Further, the commission must recommend specific measures and reforms related to realigning (1) USCP priorities and practice to address disparate use of force and surveillance targets in and around the Capitol; and (2) USCP recruitment, hiring, and retention policies and practices to address conscious and unconscious biases.

In committee Mar 4, 2021 1 co-sponsor
Co-sponsor HR 262
In committee · United States House · Co-sponsor
Federal Death Penalty Prohibition Act

Federal Death Penalty Prohibition Act This bill prohibits the imposition of a death penalty sentence for a violation of federal law. A person sentenced to death before enactment of this bill must be resentenced.

In committee Mar 4, 2021 1 co-sponsor
Co-sponsor HR 151
In committee · United States House · Co-sponsor
Preventing Future Pandemics Act of 2021

Preventing Future Pandemics Act of 2021 This bill establishes measures to address global public health risks posed by wildlife markets, which are commercial markets that sell or slaughter wildlife for human consumption as food or medicine in communities where alternative nutritional or protein sources are available. Specifically, the bill prohibits importing, exporting, purchasing, or selling live wild animals in the United States for human consumption as food or medicine. The Department of the Interior must hire, train, and deploy at least 50 new U.S. Fish and Wildlife Service law enforcement attachés around the world, and the U.S. Agency for International Development must increase specified activities to address the threats and causes of zoonotic (animal-to-human transmission) disease outbreaks. Additionally, the United States must work with other United Nations member states to urge a global ban on commercial wildlife markets and enforcement of laws to end wildlife trafficking. Further, the President may impose sanctions against a foreign country or foreign nationals that the Department of State has determined are taking certain actions that enable or facilitate commercial wildlife markets. Among other reports required by the bill, the National Academies of Sciences, Engineering, and Medicine must conduct a study and submit a report that includes an evaluation of (1) the impact that consumption of terrestrial wildlife as food or medicine has on the transmission of novel viral and other pathogens, (2) the role of consuming terrestrial wildlife as food or medicine in the transmission of microbes from animals to humans, and (3) the conditions at live wildlife markets that lead to this transmission.

In committee Mar 4, 2021 1 co-sponsor
Co-sponsor HR 153
In committee · United States House · Co-sponsor
Protecting Consumer Access to Generic Drugs Act of 2021

Protecting Consumer Access to Generic Drugs Act of 2021 This bill prohibits the manufacturer of a brand-name, generic, or biosimilar drug from entering into certain agreements to resolve or settle a patent infringement claim in connection with the sale of a drug or biological product. Specifically, such an agreement shall, with some exceptions, be a violation of the bill if the filer of a subsequent application to market a drug or biological product receives anything of value and agrees to limit or forego research, development, manufacturing, marketing, or sales of the subsequent drug or biological product. (Typically, a subsequent application seeks to market a generic or biosimilar version of a patented drug or biological product.) Penalties for violations of the bill include civil penalties and loss of the 180-day exclusivity period for a generic drug. The Federal Trade Commission (FTC) shall have exclusive authority to litigate to enforce the bill. When a generic or biosimilar drug manufacturer enters into an agreement with another drug manufacturer related to the manufacturing, marketing or sale of a drug, the manufacturers shall certify that the material they have given the FTC concerning the agreement contains (1) the complete agreement; and (2) any agreements related to the main agreement, including descriptions of any oral agreements or representations.

In committee Mar 4, 2021 1 co-sponsor
Showing 2,411 to 2,420 of 2,557 bills